Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review
Background Metastatic breast cancer (MBC) treatment has changed substantially over time,
but we do not know whether survival post-metastasis has improved at the population level …
but we do not know whether survival post-metastasis has improved at the population level …
Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival
J Chubak, DM Boudreau, HS Wirtz… - Journal of the …, 2013 - academic.oup.com
Studies of the effects of exposures after cancer diagnosis on cancer recurrence and survival
can provide important information to the growing group of cancer survivors. Observational …
can provide important information to the growing group of cancer survivors. Observational …
Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2–metastatic breast cancer in the United States: A SEER‐Medicare population‐based …
Background Evidence on overall survival (OS) with cyclin‐dependent kinase 4 and 6
(CDK4/6) inhibitors is generally limited to data from clinical trials or a few observational …
(CDK4/6) inhibitors is generally limited to data from clinical trials or a few observational …
Patterns of metachronous metastases after curative treatment of colorectal cancer
YRBM van Gestel, IHJT de Hingh… - Cancer …, 2014 - Elsevier
Background This study aimed to provide information on timing, anatomical location, and
predictors for metachronous metastases of colorectal cancer based on a large consecutive …
predictors for metachronous metastases of colorectal cancer based on a large consecutive …
Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study
Importance There are long-standing interests in the potential benefits of vitamin D for
preventing breast cancer recurrence and mortality, yet data from prospective cohort studies …
preventing breast cancer recurrence and mortality, yet data from prospective cohort studies …
Racial and ethnic bias in risk prediction models for colorectal cancer recurrence when race and ethnicity are omitted as predictors
S Khor, EC Haupt, EE Hahn, LJL Lyons… - JAMA Network …, 2023 - jamanetwork.com
Importance Including race and ethnicity as a predictor in clinical risk prediction algorithms
has received increased scrutiny, but there continues to be a lack of empirical studies …
has received increased scrutiny, but there continues to be a lack of empirical studies …
Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence
DS Carrell, S Halgrim, DT Tran… - American journal of …, 2014 - academic.oup.com
The increasing availability of electronic health records (EHRs) creates opportunities for
automated extraction of information from clinical text. We hypothesized that natural language …
automated extraction of information from clinical text. We hypothesized that natural language …
[HTML][HTML] Natural language processing to identify advance care planning documentation in a multisite pragmatic clinical trial
Context Large multisite clinical trials studying decision-making when facing serious illness
require an efficient method for abstraction of advance care planning (ACP) documentation …
require an efficient method for abstraction of advance care planning (ACP) documentation …
Natural language processing to identify cancer treatments with electronic medical records
PURPOSE Knowing the treatments administered to patients with cancer is important for
treatment planning and correlating treatment patterns with outcomes for personalized …
treatment planning and correlating treatment patterns with outcomes for personalized …
Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data
Objectives Most population-based cancer databases lack information on metastatic
recurrence. Electronic medical records (EMR) and cancer registries contain complementary …
recurrence. Electronic medical records (EMR) and cancer registries contain complementary …